Papaveretum

Papaveretum is a narcotic analgesic. Papaveretum is a mixture of poppy plant derivatives, 50%is morphine. its action is predominantly the result of its morphine content. It relieves moderate to severe pain. It also suppresses cough and produces feeling of well being. Papaveretum is administered parentrally.

Brands
Adult Dose
Dose: 0.142 to 0.285 mg/kg
Single Dose: 0.21 (0.2135)
Frequency: As recommended.
Route: IM
Instructions: As Required
Neonatal
Paedriatic
Characteristics
. It is of Natural origin. It belongs to OPIATE agonist pharmacological group on the basis of mechanism of action and also classified in Analgesic pharmacological group.It is strongly acidic drug.
Contraindications
Papaveretum is contraindicated in conditions like Renal diseases,Respiratory disease,Hepatic disease.
Effects
Papaveretum produces potentially life-threatening effects which include Respiratory depression. which are responsible for the discontinuation of Papaveretum therapy.The signs and symptoms that are produced after the acute overdosage of Papaveretum include Bradycardia, Cardiac arrest, Cyanosis.The symptomatic adverse reactions produced by Papaveretum are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea and vomiting.
Indications
Papaveretum is primarily indicated in conditions like Pain, and can also be given in adjunctive therapy as an alternative drug of choice in Surgery.
Interactions
Papaveretum is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholCarbamazepineCimetidine (HCl)Dexamphetamine (Sulphate)EtomidateHydroxyzine These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Inj Protect from Sunlight.
Warnings
Initial dose should be reduced in elderly, patient of hepatic, pulmonary or renal function, myxedema or hypothyroidism, central nervous system depression or coma, prostatic hypertrophy and gall bladder.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.